Hemifacial spasm …

Toby C Yaltho MD

Movement Disorders

Updated 10.24.2024
Released 03.07.1995
Expires For CME 10.24.2027

Hemifacial spasm

Author: Toby C Yaltho MD

See Contributor Disclosures

Editor: Robert Fekete MD

Hemifacial spasm

In This Article

Quick Link

Introduction

Overview

Hemifacial spasm is a peripherally induced movement disorder characterized by repetitive involuntary contractions of muscles innervated by the ipsilateral facial nerve. The author reviews clinical features, etiology, pathogenesis, and treatment of hemifacial spasm.

Key points

	• Hemifacial spasm is a peripherally induced movement disorder, affecting up to 14.5 per 100,000 persons.
	• Repetitive clonic or more sustained spasms synchronously affect muscles innervated by the facial nerve.
	• Compression of the facial nerve at its junction with the brainstem, by vascular or other structures (including neoplasms), appears to cause secondary hyperexcitability of the facial nucleus that seems to underlie most cases of hemifacial spasm.
	• Routine or specialized neuroimaging studies may be helpful in diagnosing or treating hemifacial spasm.
	• Botulinum toxin injections into affected facial muscles are highly effective as long-term treatment. In patients who fail botulinum toxin, microvascular decompression of the facial nerve should be considered.

Historical note and terminology

Unilateral facial spasm in association with a left vertebral artery aneurysm was first described by Schultze in 1875 (125). In 1888, Gowers further described the syndrome and differentiated it from other facial movements. He noted the clonic nature, propensity to affect the orbicularis oculi, concomitant stapedius involvement, adult onset, predominance in women, and organic nature of the disorder (58). Later, the syndrome was elaborated by Brissaud (18; 30) and Babinski (10). The first major clinical review, by Ehni and Woltman, appeared in 1945 (41). The now widely accepted association between hemifacial spasm and compression of the facial nerve by vascular structures was proposed in 1947 by Campbell and Keedy (20).

Clinical manifestations

Presentation and course

Hemifacial spasm is characterized by intermittent twitching of the muscles supplied by a single facial nerve, which differentiates this movement disorder from blepharospasm, typically a bilateral disorder, and other facial dyskinesias (76; 158; 97). Although the disorder is well-known to neurologists, the diagnosis may be delayed by several years. In fact, in a survey of 866 patients with dystonia or hemifacial spasm treated in 14 movement disorders centers in Canada, the mean time between symptom onset and diagnosis was 5.4 years (79).

Hemifacial spasm in husband and wife

Both wife and husband have left hemifacial spasm. This peripherally induced movement disorder appears to be much more common in the Asian population than among Caucasians. (Contributed by Dr. Joseph Jankovic.)
Hemifacial spasm due to airbag injury

This woman developed left hemifacial spasm after an airbag was deployed in a motor vehicle accident. The spasms are relieved by botulinum toxin. She exhibits mild left facial weakness. The left palpebral fissure is narrower than t...
Hemifacial spasm improved with botulinum toxin

This woman has left hemifacial spasm. She exhibits spontaneous synkinetic contractions of her facial muscles. Note the elevation of the left side of her mouth occurring together with partial blinks of her left eye. The left palpeb...

Onset is generally between the second and eighth decades of life and averages between 45 and 51 years of age (41). About 7% of cases present at or before the age of 30 (136). Onset during infancy is atypical and usually indicates an underlying tumor (45; 17). Women account for about 60% of cases. Hemifacial spasm has been found to be more common in the Asian population than in other populations (155). Although familial cases have been reported (100), most are sporadic. In one series of 10 patients in five families and review of 13 historical familial cases, the likely pattern of inheritance was autosomal dominant with incomplete penetrance. No clinical differences were seen in familial cases compared to sporadic cases, including response to microvascular decompression, suggesting that inherited cases share the same relationship with vascular compression as sporadic cases (102). A mother and son were described to have young-onset familial hemifacial spasm secondary to a neurovascular contact between their right facial nerve and a branch of their right posterior inferior cerebellar artery (114).

Hemifacial spasm may be a sequela of facial nerve damage or reflect a structural lesion of the nerve or its surroundings (secondary hemifacial spasm). Approximately 5% of cases have a prior history of Bell palsy and a similar number have comorbid trigeminal neuralgia (147).

Primary hemifacial spasm begins in the periorbital region, usually the lower lid, in 60% to 90% of cases. Those with secondary hemifacial spasm often notice the spasms in perioral and periorbital muscles at onset (31). Wherever the onset, the movements gradually spread to involve other muscles supplied by the ipsilateral facial nerve. When multiple facial muscles are involved, the spasms are synchronous in all ipsilateral muscles (147). Some patients have spread to the contralateral side. In one report of 10 bilateral cases, the latency for contralateral development of spasms averaged 33.3 months. In his 1905 paper, Babinski described paradoxical synkinesis in hemifacial spasm, known as “the other Babinski sign”: “When orbicularis oculi contracts and the eye closes, the internal part of the frontalis contracts at the same time, the eyebrow rises during eye occlusion” (37). This “other Babinski sign” is typically present in hemifacial spasm but not in essential blepharospasm, and although it was found to have only 25.3% sensitivity, it differentiates hemifacial spasm from blepharospasm with 100% specificity (133). The disability that results from hemifacial spasm relates to multiple areas of function. More than 75% of patients are embarrassed by the spasms, and 15% to 65% complain of depressive symptoms (06). The spasms affect vision in about 60% of patients and interfere with work in about 36% (06).

Hemifacial spasm

Occasional clonic spasms occur at rest, exacerbated by talking. (Contributed by Dr. Kathleen Shannon.)

The facial twitches in patients with hemifacial spasm may be clonic or tonic, and it is common for episodes to begin as multiple clonic spasms and culminate in sustained tonic contraction. Spasms occur spontaneously but are exacerbated by voluntary facial movement, stress, fatigue, anxiety, or change in head position (41). Although significantly decreased compared to wakefulness causing arousals, hemifacial spasm persists during sleep (68). The movements often persist during sleep. Stapedius muscle contraction frequently accompanies contraction of the muscles of facial expression and sometimes produces low-pitched tinnitus in the ipsilateral ear (150; 151). However, evidence of spontaneous activity in nonmotor functions, such as lacrimation and salivation, is not seen (53). Clinically apparent facial weakness may be seen in longstanding cases and is demonstrable with objective testing in the eyelid in 47% and other facial muscles in 77% of cases (48). Other cranial nerves, particularly the acoustic nerve, may be involved. As many as 50% of patients have abnormalities of the acoustic middle-ear reflex (105) and some degree of hearing loss can be found in nearly 15% (41). Concurrent trigeminal nerve dysfunction results in the syndrome named by Cushing, "painful tic convulsif." It has been estimated that 0.2% to 11% of patients with trigeminal neuralgia have associated hemifacial spasm (98). Coexistence with blepharospasm has also been reported (137). In a study of 95 patients, hand tremor accompanied hemifacial spasm in 40% of cases and 10% of control subjects (119).

Prognosis and complications

Hemifacial spasm is a chronic condition. Spontaneous resolution occurs in fewer than 10% of cases (41). Although early in the course the facial twitching may be no more than a nuisance, progression is the rule. Severe involvement can cause disability due to loss of binocular vision. There are no known complications of untreated hemifacial spasm.

In a retrospective study of 142 consecutive patients with hemifacial spasm who underwent microvascular decompression performed by a single surgeon between November 2019 and May 2021, 90(63.3%) were classified as rapid progression group and 52(36.7%) were classified as slow progression group. Risk factors for rapid progression were an onset age of older than 45 years, facial nerve angle of 96.5° or smaller, severe compression of the brainstem by offending vessels, and positive expression of APOE ε4 (156).

Clinical vignette

A 44-year-old right-handed woman developed twitching of the right eyelid. She gradually noticed spread of the movements to the lower part of the face over the course of months. MRI brain was negative. She was treated with clonazepam and carbamazepine without relief. She had no significant medical history and no family history of movement disorders. Neurologic examination abnormalities were limited to the face. There were nearly continuous rapid synchronous contractions of the right side of the face. Injections of 25 units of botulinum toxin A at four sites over the orbicularis oculi significantly reduced the movements.

Hemifacial spasm patient before and after botulinum toxin injection

44-year-old woman with 3-year history of right hemifacial spasm is first shown before botulinum toxin injection. After botulinum toxin injection, there is a dramatic reduction in right hemifacial spasm. (Contributed by Dr. Kathlee...

Biological basis

Etiology and pathogenesis

Hemifacial spasm is thought to result from compression of the facial nerve at its junction with the brainstem (97). Rarely, compression along the course of the nerve outside of the cranium has been reported to cause hemifacial spasm (117). In most cases, the compression is by blood vessels adjacent to the zone of exit of the facial nerve (150; 151). Contralateral fusiform aneurysms of the vertebral artery causing hemifacial spasm have also been reported (106). Digre reviewed 1688 cases of hemifacial spasm from the literature. In the 539 cases where etiology was specified, the cause of hemifacial spasm was compression by vascular structures in 94%, tumor in 4%, and bony or other abnormalities in 2%. In a series of 1642 hemifacial spasm cases, only nine resulted from a cause other than neurovascular compression (seven tumors, two vascular malformations) (60). Causative tumors include epidermoid neuroma, meningioma or astrocytoma of the cerebellopontine angle, petrous ridge meningioma, and parotid tumor. In a series of nine patients with cerebellopontine angle tumors, there were two vestibular schwannomas, five meningiomas, and two epidermoid tumors (92). Cerebropontine lipomas have also been shown to cause unilateral hemifacial spasm (39). Basilar impression, cranio-occipital malformation, and Paget disease were etiologic in a few cases (38). Other rare causes of hemifacial spasm are large posterior fossa masses, Chiari I malformation, and brainstem cysticercosis. Hemifacial spasm has been reported to result from parotid tumor (16). Transient hemifacial spasm has been reported in the context of diabetic ketoacidosis (13) and mandibular trauma (128). Hemifacial spasm has also been reported in patients with multiple sclerosis (99) and ocular myotonia (83). There have been a few cases of idiopathic intracranial hypertension associated with hemifacial spasm (116; 52).

Vascular compression or irritation of the facial nerve is the most common pathogenic mechanism of hemifacial spasm. Dolichoectatic vertebrobasilar arteries or compression of the facial nerve root exit zone can be demonstrated in up to 96% of cases using computed tomography scan, modified magnetic resonance imaging, 3-dimensional fast-spin magnetic resonance imaging, surface-rendered 3-dimensional magnetic resonance imaging, 3-dimensional phase contrast magnetic resonance angiography, or magnetic resonance tomographic angiography techniques (50; 111). In a study of 115 consecutive hemifacial spasm patients undergoing microvascular decompression, all patients had neurovascular compression (21). The offending vessel was the anterior inferior cerebellar artery in 43%, posterior inferior cerebellar artery in 31%, vertebral artery in 23%, and a large vein in 3%. Thirty-eight percent of patients had more than one compressing vessel. Along the course of the facial nerve, compression was most frequent at its attached segment and less common in the root detachment point, root exit point, and distal cisternal portion. A case report revealed 2 mm longitudinal penetration of the distal portion of the facial nerve root exit zone by the anterior inferior cerebellar artery as a cause of hemifacial spasm (112). In another case report anomalous, enlarged branch of the ascending pharyngeal artery was found to be the cause of hemifacial spasm (141).

Hypertension may play an important role in the genesis of hemifacial spasm. In a case-control study of patients with primary hemifacial spasm, hypertension was more common in cases than controls (odds ratio 2.76; 95% CI 1.43-5.33). Subjects with hemifacial spasm and hypertension are more likely to have imaging evidence of ventrolateral medullary compression than nonhypertensive subjects (36; 23). Neuroimaging of controls with hypertension reveals evidence of ventrolateral medullary compression in nearly 75% of cases (23; 26). It is important to recognize that among control subjects, neuroimaging studies suggest a sizeable number have areas of contact between the facial nerve and vascular structures (49%) or indentation of the ventrolateral medulla (41%), and this number is increased significantly in the presence of hypertension (72%) (23; 80). A prospective controlled study using 3-dimensional MR volumetric analysis showed that patients with hemifacial spasm have 11.4% smaller CSF volume in the posterior fossa (24). A study of voxel-based morphometry used to evaluate changes in gray matter by using T1-weighted imaging in 25 patients with hemifacial spasm and 25 demographically similar healthy volunteers found reductions in the thalamus, putamen, pallidum, dorsolateral prefrontal cortex, amygdala, and parahippocampal gyrus in patients with hemifacial spasm compared with healthy volunteers (14). Another voxel-based morphometry study found grey matter volume was reduced in the right inferior parietal lobule and increased in the cerebellar lobule in eight of 42 patients with hemifacial spasm, when compared with 30 control subjects (144).

Support for the theory that compression of the nerve at the root exit zone incites the development of hemifacial spasm comes from several sources. Neuroimaging studies frequently show contact between the nerve and the offending structures. Biopsies of root exit zones of compressed nerves from patients with hemifacial spasm show demyelination of axis cylinders or nerve degeneration (29). Surgical relief of compression in the region is usually successful in relieving the disorder (75). However, the mechanism of production of spasm is unknown. The theory that focal demyelination or nerve degeneration causes aberrant regeneration similar to that which follows facial nerve injury is untenable as it fails to explain the spasms’ spontaneity and synchronous occurrence in muscles supplied by different nerve branches.

An alternative theory of "ectopic" or "ephaptic" transmission was proposed by Gardner and has been championed by Nielsen (53; 107; 108). According to this theory, nerve compression and the resulting demyelination cause an "ephapse" to form. An ephapse is a false synapse where ectopic activity may be triggered by mechanical irritation, changes in regional electrolyte concentration, or flow of extracellular current during passage of nerve impulses in adjacent fibers (108). This ectopic activity may then be conducted orthodromically or antidromically within the nerve fiber. Nielsen has studied electrical phenomena that seem to support this theory. When the zygomatic branch of the facial nerve is stimulated in hemifacial spasm, a direct response is obtained in the orbicularis oculi muscle just as in normal controls. However, in hemifacial spasm, there is also a response in the mentalis muscle, which is supplied by the mandibular branch muscle and not seen in the unaffected side or in normal controls (108). The authors concluded that lateral spread of current to branches of the nerve other than those stimulated occurs by means of crosstalk at the compressed area of the nerve. Following surgical relief of vascular compression of the facial nerve, these electrophysiologic abnormalities resolve (08). Sanders used single fiber EMG to determine whether nonsynaptic transmission occurred between branches of the facial nerve. "Jitter," variations in latency between the presynaptic stimulus and the muscle response, is a measure of synaptic delay. The demonstration in two patients with hemifacial spasm that jitter was low suggested that inappropriate spread to other muscles occurred by nonsynaptic means (122). This further supports the notion of ephaptic transmission. Motor unit potential analysis suggests the demyelination causes secondary axonal loss in hemifacial spasm (84). Reduction in the lateral spread response amplitudes in the orbicularis oculi, orbicularis oris, and mentalis muscles by desflurane suggests a central mechanism is involved in the lateral spread response (152).

However, additional studies suggest that the point of generation of abnormal activity is central to the area of vascular compression. During microvascular decompression operations, Moller recorded the conduction time from a stimulation site on the marginal mandibular branch of the facial nerve to the facial root exit zone (104). He then recorded the latency from stimulation at the root exit zone to the muscle response in the orbicularis oculi. The latency from marginal mandibular stimulation to orbicularis oculi contraction exceeded by 2 msec the sum of conduction times from the marginal mandibular branch to the root exit zone and from the root exit zone to the orbicularis oculi (104). The F wave, an indicator of motoneuron conduction and anterior horn excitability, is enhanced in patients with hemifacial spasm (71).

Patients with hemifacial spasm have a lower threshold to transcranial magnetic stimulation on the affected side (85), and paired transcranial magnetic stimulation shows a lessening of facilitation of the test motor evoked potential by the conditioning stimulus at certain interstimulus intervals, suggesting changes in facial motor neuron excitability (22). Patients with hemifacial spasm have enhanced F waves on the symptomatic side, another sign of increased excitability of the facial nucleus (110). Hyperexcitability of the blink reflex (40) and F waves (70; 69) in patients with hemifacial spasm further support this theory of pathogenesis. These studies suggest that the abnormal activity is generated central to the exit zone, probably at the facial nucleus. Moller proposed that aberrant afferent activity generated at the site of vascular compression caused reorganization of the facial nucleus by a mechanism similar to the "kindling" phenomenon described in the hippocampus (103). Following surgical decompression in 20 patients with hemifacial spasm, the excitability of the F wave decreased in patients who had only partial resolution of spasm postoperatively. In patients whose spasms disappeared completely after surgery, F-wave hyperexcitability completely resolved, though over a time course of up to two years (70). Successful botulinum toxin injection may also be associated with reductions in facial motor nucleus hyperexcitability as assessed with F waves (72). In patients, the electrophysiologic abnormalities of hemifacial spasm can be produced by repetitive simulation of the facial nucleus. It is also possible to induce facial nucleus hyperexcitability and the electrophysiologic abnormalities of hemifacial spasm by producing an area of demyelination and vascular compression at the facial nerve exit zone (89).

Differential diagnosis

Confusing conditions

Hemifacial spasm must be differentiated from other conditions that cause involuntary facial movements. These include conditions wherein the abnormal movement is organized at the lower motor neuron level as well as those wherein the brainstem or higher structures are involved. In a series of 215 patients referred to a tertiary movement disorders center for evaluation of involuntary facial movements, there were 38 (18%) patients with hemifacial spasm mimickers classified as psychogenic, tics, dystonia, myoclonus, and hemimasticatory spasm (158).

Postparalytic facial spasms. Postparalytic facial spasms generally reflect either fixed contraction of the facial muscles, synkinesis, or both. There is always a history of preceding facial weakness, and spontaneous spasms are generally absent.

Facial myokymia. Facial myokymia is characterized clinically by undulating movement of facial muscles. Electrophysiologically, there is rhythmic bursting of single muscle fascicles. The frequency of motor unit discharge ranges from 20 to 200 Hz. The bursts are asynchronous in various muscles of the face as well as in different motor units in the same muscle.

Spastic paretic facial contracture. Spastic paretic facial contracture may be confused with hemifacial spasm. The involved side is weak and contracted, unlike hemifacial spasm, wherein the facial muscles are relaxed between twitches. The presence of concomitant myokymia is also helpful in distinguishing the conditions. Spastic paretic facial contracture usually indicates focal pathology in the brainstem.

Blepharospasm and Meige syndrome. Blepharospasm and Meige syndrome are forms of focal dystonia. In blepharospasm, dystonic movements involve the orbicularis oculi muscle. Meige syndrome includes blepharospasm and dystonic movements of the lower face. Because Meige was not the first to describe the disorder, the term cranial dystonia is more appropriate for the combination of upper and lower face dystonia. Dystonic movements are generally bilateral and improve during sleep. Upper and lower facial involvement is generally not synchronous. When the lower face is involved, there is often clinically apparent involvement of muscles other than those innervated by the facial nerve.

Tics. These are rapid, stereotyped movements that resemble normal, coordinated movement. They vary in intensity and are arrhythmic. Tic sufferers are usually able to voluntarily reproduce and to transiently suppress the movements. Although tics frequently affect the orbicularis or facial muscles, most patients have additional tics in muscles not supplied by the facial nerve.

Tardive dyskinesia. This results from chronic treatment with dopamine receptor-blocking agents. Movements may be choreic or dystonic. Most often bilateral, the movements are irregular, and when upper and lower face are involved, are usually asynchronous and involve additional muscles other than those innervated by the facial nerve.

Psychogenic hemifacial spasm. These patients have more frequent tonic muscle contractions, bilateral asynchronous hemifacial involvement, isolated lower facial involvement, downward deviation of the mouth’s angle, and lack of the “other Babinski sign” compared to those with organic hemifacial spasm (12).

Diagnostic workup

The need for a diagnostic workup in patients with classic hemifacial spasm is debatable. Aberrant vessels have been identified by contrast-enhanced computed tomography (38), magnetic resonance imaging (140), and modified magnetic resonance angiography studies (01; 142) in 80% to 100% of patients with hemifacial spasm in some series. Using advanced magnetic resonance imaging techniques with 3-dimensional fast spin echo and the minimum intensity projection method enhances the ability to visualize vascular structures compressing the facial nerve (101). Three-dimensional MR cisternography was said to have 100% sensitivity and 94% specificity for vascular compression in a series of 14 patients with hemifacial spasm compared to 20 control subjects (91). Another high-yield magnetic resonance technique is 3-dimensional constructive interference in steady state (CISS). This technique showed 100% sensitivity for identifying vascular structures compressing the facial nerve in a study of 47 subjects with hemifacial spasm (139), but only 77.27% sensitivity and 75% specificity in another study of 44 patients with hemifacial spasm and 76 controls (56). Vertebral angiography adequately visualizes the offending vessels in a large number of cases and may increase the safety of surgical interventions (113). Tumors are rarely identified. In a survey of 190 investigators comprising treatment records of 1676 patients with hemifacial spasm, only nine tumors were found. Indeed, only 881 patients had neuroimaging studies (132). This reflects a change in patient management away from surgery and towards more conservative treatment strategies, such as botulinum toxin injection. Patients who are clinically atypical with signs of regional focal pathology should have neuroimaging studies. In this group, magnetic resonance imaging is the imaging study of choice. Thin-slice T2 MRI imaging of the facial nerve can guide clinicians in selecting patients who are good surgical candidates (126). A study of cerebral glucose metabolism using PET with (18) F-fluorodeoxyglucose demonstrated bilateral cerebral glucose hypermetabolism in the thalamus of patients with unilateral hemifacial spasm (127). Patients who do not improve with conservative management and who are candidates for surgical intervention should have neuroimaging at the discretion of the operating surgeon. Preoperative auditory screening may also be useful.

A study of inflammatory makers demonstrates that serum level of interleukin-6 correlated with the severity of hemifacial spasm (95).

Management

Several treatment options involving oral medications are available to the physician. Most trials of oral medications have been empiric and uncontrolled. The clinical similarities between trigeminal neuralgia and hemifacial spasm suggest that anticonvulsant therapy may be useful. Carbamazepine is often the first intervention. Alexander and Moses reviewed published reports of carbamazepine therapy of hemifacial spasm in 46 patients in seven series. Sustained improvement was seen in 35% and complete control in an additional 22% of cases (03). An open-label trial of gabapentin in 23 patients with hemifacial spasm showed significant reduction of spasm in 16 (34). Hughes studied orphenadrine and dimethylaminoethanol in a placebo-controlled trial in 13 patients with hemifacial spasm. He found that 62% of patients in this study had a beneficial response to anticholinergic medication (64). Sandyk and Gillman reported beneficial effects of baclofen in six patients in open trials (123). Other medications sometimes used in the treatment of hemifacial spasm include haloperidol and clonazepam. However, in 2015 a randomized double-blind placebo-controlled trial of clonazepam 0.5 mg twice a day versus placebo for four weeks did not show a statistically significant effect on hemifacial spasm (11). Levetiracetam may be beneficial in the treatment of hemifacial spasm (88). Anecdotal reports in hemifacial spasm associated with Paget disease suggest that treatment of the bone disorder with calcitonin or alendronate may improve the facial spasms (49).

There have been numerous extracranial neurosurgical approaches to the treatment of hemifacial spasm. Unilateral removal of the orbicularis oculi, corrugator superciliaris, and procerus muscles may be effective in controlling spasm around the eye, but offers no benefit for lower facial spasm. Adverse effects are mild (54). Early procedures included sectioning or injuring the peripheral nerve trunk or its branches. These procedures may relieve spasms but are accompanied by various degrees of facial weakness. Although facial strength often returns in 3 to 6 months, it is invariably accompanied by return of the facial spasms. A modification of this procedure wherein an anastomosis is made between the hypoglossal or spinal accessory nerve and the severed facial nerve in an attempt to prevent regrowth of the nerve does not significantly improve the results (150; 151). Attempts to injure the facial nerve using injections of alcohol or phenol afford only transient benefit. Other extracranial procedures include transtympanic puncture of the nerve (109) or insertion of tantalum wire into the nerve, decompression or longitudinal neurotomy in the facial canal, and radiofrequency thermocoagulation of the facial nerve. In all cases, facial weakness accompanies relief of spasms and both facial strength and spasms return in time (150; 151). Somewhat longer-lasting benefit has been achieved in patients treated by percutaneous puncture of the facial nerve at the stylomastoid foramen. Although facial palsy and relief of spasm are immediate, facial strength returns before the spasms. Extreme pain accompanies this procedure, and patients are often unwilling to undergo repeated treatments (74). Ito and colleagues described a technique of permanent selective facial nerve block using doxorubicin under local anesthesia in a 73-year-old woman with hemifacial spasms, but further investigation of this technique is required (73).

Intracranial surgical procedures have been used for the treatment of hemifacial spasm for more than 50 years (97). In 1962, Gardner reported the results of microvascular decompression of the facial nerve in the cerebellopontine angle in 19 patients. Janetta and others have subsequently reported large series of patients treated in this fashion. Review of 18 such series, comprising 4969 patients, reveals that 58% to 97% of patients markedly improved following one or more procedures. Overall, 84% had good to complete resolution of spasm, and 4% failed to respond. Recurrence rates varied from 0.4% to 10% (43; 153; 81; 86; 74; 44; 96; 07; 78; 150; 63; 02; 151; 15; 67; 129; 65). A prospective study of 1174 patients with hemifacial spasm who underwent microvascular decompression suggested a “cure” in 94.1% of cases (66). In another study, a metaanalysis of 39 studies including 6249 patients who underwent microvascular decompression surgery revealed that the overall spasm freedom rate was 90.5% at a follow-up of 1.25 ± 0.04 years (62). In a study of 76 elderly patients with hemifacial spasm treated with botulinum toxin and microvascular decompression and at least 2 years of follow-up (median, 44.5 months), 84.2% were spasm-free at last follow-up (145).

As many as 50% of surgically treated patients have transient recurrence postoperatively beginning around four days postoperatively and improving gradually, with a median time to resolution of 28 days (69). The University of Pittsburgh investigators described the results of 41 repeat microvascular decompression procedures in 36 patients over a 3-year period; 5.9% of them failed the reoperation (42). Another study of 78 patients who had repeat microvascular decompression surgery revealed that 72 (98%) achieved complete resolution (157). Follow-up MRI imaging suggests that the degree of vascular depression afforded by the operative procedure does not predict the magnitude of subsequent benefit (25). In two studies that included 276 patients who were followed for 10 years, 90% had excellent recovery (57; 121). Follow-up of 25 cases of hemifacial spasm following decompression showed improvements in quality of life (61; 27). Some authors advocate intraoperative recording of facial nerve-innervated muscles as a prognostic indicator. A decrease in the lateral spread response (activity in muscles innervated by one or more branches of the facial nerve following electrical stimulation of another facial nerve branch) after relieving pressure on the facial nerve root entry zone predicts prognosis in some (87), although this remains controversial (35; 146). In another study, intraoperative facial nerve motor evoked potentials elicited by transcranial electrical stimulation were monitored (51). A reduction in facial nerve motor evoked potentials in the orbicularis oculi at the procedure end was associated with clinical improvement. In a study of 1335 patients who underwent microvascular decompression surgery, patients were classified as rapidly progressive or slowly progressive (90). The study found the following significant predisposing factors for rapid progression: patients were younger age at surgery, older age at symptom onset, and absence of intraoperative facial nerve indentation. The rapidly progressive group had worse outcomes than the slowly progressive group following microvascular decompression.

Complications of microvascular decompression are common, but most are not serious. In large series, up to 35.8% of consecutive patients have one or more complications, including facial palsy (7% to 18.6%), hearing deficit (1% to 7.2%), and lower cranial nerve palsies (2.8%) (65; 66). Facial palsy may be delayed up to 16 days following surgery. High-frequency hearing loss has been reported on both the ipsilateral and contralateral sides following surgery (159). Intraoperative monitoring of the brainstem auditory evoked potential may reduce the likelihood of permanent deafness by allowing surgeons to modify their technique in response to changes in the waveform (131). Other complications of these procedures include facial or scalp hypesthesia, dysequilibrium, encephalopathy, anosmia, aseptic or bacterial meningitis, phlebitis, serous otitis media, wound infection, cerebrospinal fluid rhinorrhea, tension pneumocephalus, pneumonia, pulmonary embolus, and gastrointestinal bleeding (63). Death (153) and brainstem infarction (120) are rare complications. Elderly patients have a similar response to surgery and side effect profile, according to one study (77). Endoscopic vascular decompression has shown comparable efficacy to microvascular decompression with less morbidity and shorter hospital stay (05).

In a series of three patients, radiosurgery (single dose of 3 Gy in one patient) and hyperfractionated stereotactic radiotherapy (15 Gy divided into five fractions in two patients) targeting the vestibulocochlear-facial bundle just outside the internal acoustic foramen resulted in markedly reduced symptoms over a mean follow-up duration of 24 months (46).

Hemifacial spasm related to nerve compression by large vascular structures, such as arteriovenous malformations or fusiform aneurysms of the basilar artery, may be amenable to treatment with endovascular embolization (124).

Botulinum toxin has emerged as the treatment of choice for hemifacial spasm (82; 59). For the treatment of hemifacial spasm, botulinum toxin is injected into the subcutaneous tissue overlying the orbicularis oculi muscle at 3 to 10 sites around the eye. When lower facial spasms are disabling, small amounts of toxin may be injected into the lower facial muscles as well. A systematic review of published clinical trials revealed only one small placebo-controlled study of botulinum toxin A, which supported the conclusions of multiple open-label studies (32). A review of published articles between 1991 and 2021 regarding the effectiveness and safety of botulinum toxin in hemifacial spasm as well as any reported differences among botulinum toxin showed that efficacy of BoNT for hemifacial spasm treatment ranged from 73% to 98.4% (135). A cross sectional study of 1003 patients with hemifacial spasm at 15 tertiary centers in China demonstrated a mean latency of botulinum toxin A effect was (5.0 ± 4.7) days, and the mean total duration of the effect was (19.5 ± 11.7) weeks (148). A randomized, double-blind crossover trial of 20 patients revealed no significant difference in the onset time and therapeutic efficacy between high concentration (50 U/mL) and low concentration (25 U/mL) groups; however, the duration of efficacy was longer in the high-concentration group than in the low-concentration group. Patients in the high-concentration group had more serious adverse reactions, and the reactions lasted for longer duration (94).

A study comparing patients with and without prior botulinum toxin treatment after microvascular decompression revealed no significant differences in the outcomes and complications after a minimum of nine months of follow-up (149). In another study that followed 976 patients with hemifacial spasm, 452 patients underwent microvascular decompression only and 524 patients first had botulinum toxin treatment then underwent microvascular decompression. The patients were followed for 7 to 9 years, and the long-term postoperative relief rate was 98.23% for the first group and 87.21% for the second group, suggesting that patients treated with microvascular decompression experience better long term efficacy (160). A report confirmed the high efficacy and safety profile of botulinum toxin A for long-term treatment of hemifacial spasm (28). The benefits of botulinum toxin are typically longer than the average 3 to 4 months seen in other indications, and the effects can be sustained for several decades (118). Common adverse effects are eyelid and facial weakness (up to 100%), ptosis (up to 23%), and diplopia (up to 13%). Less commonly reported adverse effects include excessive tearing, dry eyes, corneal exposure and keratitis, and fatigue (47). Excessive facial weakness is more common in patients in whom preexisting denervation can be demonstrated by EMG (04). In a retrospective analysis of patients with post-facial palsy synkinesis and hemifacial spasm treated with botulinum toxin, complications were higher in patients treated for post-facial palsy synkinesis (77%) compared to hemifacial spasm (34%) (19). Repeated injections are well tolerated, and benefit is maintained over years of treatment (82; 33; 134). Both serotypes A and B are effective (143). Botulinum toxin injections result in improved patient quality of life (138). An evidence-based medicine report found one class II and one class III study in support of botulinum toxin injections for hemifacial spasm (130). In a retrospective study of 16 patients who received 30 or more serial botulinum toxin A treatments, the mean duration of relief was 12.4 weeks (55). Injection of doxorubicin into the eyelids has also been reported effective for up to six years (154).

A controlled study of acupuncture and pressure on the otopoints in 86 patients suggested that the combination of these two traditional medicine approaches was superior to either technique alone (93). A questionnaire completed by 96 patients with hemifacial spasm indicated that complimentary therapies, most commonly acupuncture and facial massage, were tried in more than 50% of these patients (115).

Media

References

01: Adler CA, Zimmerman RA, Savino PJ, Bernardi B, Bosley TM, Sergott RC. Hemifacial spasm: evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography. Ann Neurol 1992;32:502-6. PMID 1456734
02: Aksik I. Microneural decompression operations in the treatment of some forms of cranial rhizopathy. Acta Neurochirugica 1993;125:64-74. PMID 8122559
03: Alexander GE, Moses H. Carbamazepine for hemifacial spasm. Neurology 1982;32:286-7. PMID 7199640
04: Angibaud G, Moreau MS, Rascol O, Clanet M. Treatment of hemifacial spasm with botulinum toxin. Eur Neurol 1995;35:43-5. PMID 7737246
05: Artz GJ, Hux FJ, Larouere MJ, Bojrab FI, Babu S, Pieper DR. Endoscopic vascular decompression. Otol Neurotol 2008;29(7):995-1000. PMID 18698270
06: Au WL, Tan LC, Tan AK. Hemifacial spasm in Singapore: clinical characteristics and patients’ perceptions. Ann Acad Med Singapore 2004;33:324-8. PMID 15175773
07: Auger RG, Piepgras DG, Laws ER. Hemifacial spasm: results of microvascular decompression of the facial nerve in 54 patients. Mayo Clin Proc 1986;61:640-4. PMID 3724243
08: Auger RG, Piepgras DG, Laws ER, Miller RH. Microvascular decompression of the facial nerve for hemifacial spasm: clinical and electrophysiologic observations. Neurology 1981;31:346-50. PMID 7193828
09: Auger RG, Whisnant JP. Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984. Arch Neurol 1990;47:1233-4. PMID 2241620
10: Babinski J. Hemispasme facial peripherique. Rev Neurol 1905;13:443-50.
11: Baek SH, Shin JY, Sohn SY, et al. Safety and efficacy of clonazepam in patients with hemifacial spasm: A double-blind, randomized, placebo-controlled trial. Parkinsonism Relat Disord 2022;103:1-6. PMID 35987013
12: Baizabal-Carvallo JF, Jankovic J. Distinguishing features of psychogenic (functional) versus organic hemifacial spasm. J Neurol 2017;264(2):359-63. PMID 27942912
13: Bandyopadhyay SK, Dutta A. Hemifacial spasm complicating diabetic ketoacidosis. J Assoc Physicians India 2005;53:649-50. PMID 16190139
14: Bao F, Wang Y, Liu J, et al. Structural changes in the CNS of patients with hemifacial spasm. Neuroscience 2015;289:56-62. PMID 25595976
15: Barker FG, Jannetta PJ, Bissonette DJ, Shields PT, Larkins MV, Jho HD. Microvascular decompression for hemifacial spasm. J Neurosurg 1995;82:201-10. PMID 7815147
16: Behbehani R, Hussain AE, Hussain AN. Parotid tumor presenting with hemifacial spasm. Ophthal Plast Reconstr Surg 2009;25(2):141-2. PMID 19300162
17: Bills DC, Hanieh A. Hemifacial spasm in an infant due to fourth ventricular ganglioglioma. J Neurosurg 1991;75:134-7. PMID 2045898
18: Brissaud E. Tics et spasmes cloniques de la face. J Med Chir Pract 1894;65:49-64.
19: Cakmak MA, Sahin S, Cinar N, Karsidag S. Complications of botulinum toxin application: differences between hemifacial spasm and post-facial palsy synkinesis. Acta Neurol Belg 2014;(4):331. PMID 24647748
20: Campbell E, Keedy C. Hemifacial spasm: a note on the etiology in two cases. J Neurosurg 1947;4:342-7. PMID 20254516
21: Campos-Benitez M, Kaufmann AM. Neurovascular compression findings in hemifacial spasm. J Neurosurg 2008;109(3):416-20. PMID 18759570
22: Celik M, Oge AE, Kilic E, Forta H. Paired transcranial magnetic stimulation in hemifacial spasm. Electromyogr Clin Neurophysiol 2004;44(2):89-94. PMID 15061402
23: Chan LL, Lee E, Fook-Chong S, Tan EK. Case control MR-CISS and 3D TOF MRA imaging study of medullary compression and hypertension in hemifacial spasm. Mov Disord 2008;23(13):1820-4. PMID 18709669
24: Chan LL, Ng KM, Fook-Chong S, Lo YL, Tan EK. Three-dimensional MR volumetric analysis of the posterior fossa CSF space in hemifacial spasm. Neurology 2009;73(13):1054-7. PMID 19786697
25: Chang JW, Chang JH, Choi JY, Kim DI, Park YG, Chung SS. Role of postoperative magnetic resonance imaging after microvascular decompression of the facial nerve for the treatment of hemifacial spasm. Neurosurgery 2002;50(4):720-5. PMID 11904021
26: Cheng J, Fang Y, Zhang H, et al. Quantitative study of posterior fossa crowdedness in hemifacial spasm. World Neurosurg 2015;84(4):920-6. PMID 26341431
27: Cheng J, Lei D, Hui X, Zhang H. Improvement of quality of life in patients with hemifacial spasm after microvascular decompression: a prospective study. World Neurosurg 2017;107:549-53. PMID 28826863
28: Cillino S, Raimondi G, Guepratte N, et al. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes. Eye (Lond) 2010;24(4):600-7. PMID 19648904
29: Coad JE, Wirtschafter JD, Haines SJ, Heros RC, Perrone T. Familial hemifacial spasm associated with arterial compression of the facial nerve. J Neurosurg 1991;74:290-6. PMID 1988602
30: Colosimo C, Berardelli A. An early image of hemifacial spasm: Edouard Brissaud contribution. Mov Disord 2010;25(5):531-3. PMID 20175213
31: Colosimo C, Bologna M, Lamberti S, et al. A comparative study of primary and secondary hemifacial spasm. Arch Neurol 2006;63(3):441-4. PMID 16533973
32: Costa J, Espirito-Santo C, Borges A, et al. Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev 2005;(1):CD004899. PMID 15674968
33: Czyz CN, Burns JA, Petrie TP, Watkins JR, Cahill KV, Foster JA. Long-term botulinum toxin treatment for benign essential blepharospasm, hemifacial spasm, and Meige syndrome. Am J Ophthalmol 2013;156(1):173-7. PMID 23541393
34: Daniele O, Caravaglios G, Marchini C, Mucchiut L, Capus P, Natale E. Gabapentin in the treatment of hemifacial spasm. Acta Neurol Scand 2001;104:110-2. PMID 11493229
35: Dannenbaum M, Lega BC, Suki D, Harper RL, Yoshor D. Microvascular decompression for hemifacial spasm: long-term results from 114 operations performed without neurophysiological monitoring. J Neurosurg 2008;109(3):410-15. PMID 18759569
36: Defazio G, Martino D, Aniello MS, et al. Influence of age on the association between primary hemifacial spasm and arterial hypertension. J Neurol Neurosurg Psychiatry 2003;74(7):979-81. PMID 12810800
37: Devoize, JL. The other Babinski's sign: paradoxical raising of the eyebrow in hemifacial spasm. J Neurol Neurosurg Psychiatry 2001;70(4):516. PMID 11254777
38: Digre K, Corbett JJ. Hemifacial spasm: differential diagnosis, mechanism, and treatment. Adv Neurol 1988;49:151-76. PMID 3278539
39: Doherty CM, Briggs G, Quigley DG, McCarron MO. An unusual cause of hemifacial spasm. Br J Neurosurg 2014:1-3. PMID 25058594
40: Eekhof JL, Aramideh M, Speelman JD, Devriese PP, Ongerboer De Visser BW. Blink reflexes and lateral spreading in patients with synkinesia after Bell palsy and in hemifacial spasm. Eur Neurol 2000;43:141-6. PMID 10765053
41: Ehni G, Woltman HW. Hemifacial spasm. Arch Neurol Psychiatry 1945;53:205-11.
42: Engh JA, Horowitz M, Burkhart L, Chang YF, Kassam A. Repeat microvascular decompression for hemifacial spasm. J Neurol Neurosurg Psychiatry 2005;76:1574-80. PMID 16227555
43: Fabinyi GC, Adams CB. Hemifacial spasm: treatment by posterior fossa surgery. J Neurol Neurosurg Psychiatr 1978;41:829-33. PMID 690654
44: Fairholm D, Wy JM, Liu KN. Hemifacial spasm: results of microvascular relocation. Can J Neurol Sci 1983;10:187-91. PMID 6604569
45: Fleuler U, Taylor D, Hing S, Kendall B, Finn JP, Brett E. Hemifacial spasm in infancy. Arch Ophthalmol 1990;108:812-5. PMID 2350284
46: Fraioli MR, Moschettoni L, Fraioli C, Strigari L. Treatment of idiopathic hemifacial spasm with radiosurgery or hypofractionated stereotactic radiotherapy: preliminary results. Minim Invasive Neurosurg 2010;53(1):34-6. PMID 20376743
47: Frei K, Truong DD, Dressler D. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations. Eur J Neurol 2006;13(Suppl 1):30-5. PMID 16417595
48: Frueh BR, Preston RA, Musch DC. Facial nerve injury and hemifacial spasm. Am J Ophthalmol 1990;110:421-3. PMID 2220979
49: Fu KK, Ko A. The treatment with alendronate in hemifacial spasm associated with Paget disease of bone. Clin Neurol Neurosurg 2000;102:48-51. PMID 10717405
50: Fukuda H, Ishikawa M, Okumura R. Demonstration of neurovascular compression in trigeminal neuralgia and hemifacial spasm with magnetic resonance imaging: comparison with surgical findings in 60 consecutive cases. Surg Neurol 2003;59:93-9. PMID 12648904
51: Fukuda M, Oishi M, Hiraishu T, Fujii Y. Facial nerve motor-evoked potential monitoring during microvascular decompression for hemifacial spasm. J Neurol Neurosurg Psychiatry 2010;81(5):519-23. PMID 19726411
52: Garcia MD, Mansukhani SA, Chen JJ, Bhatti MT. Idiopathic intracranial hypertension triggering hemifacial spasm. J Neuroophthalmol 2021;41(2):e223-4. PMID 32833859
53: Gardner WJ. Trigeminal neuralgia. Clin Neurosurg 1968;15:1-15. PMID 4945158
54: Garland PE, Patrinely JR, Anderson RL. Hemifacial spasm. Results of unilateral myectomy. Ophthalmology 1987;94:288-94. PMID 3587908
55: Gill HS, Kraft SP. Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm. Can J Neurol Sci 2010;37(5):631-6. PMID 21059510
56: Gorrino Angulo M, Sadaba Garay F, Oleaga Zufiria L, Gorrino Angulo O, Gomez Muga JJ, Bermejo Espinosa N. Study of neurovascular contact in essential hemifacial spasm: an example of CISS sequence and magnetic resonance angiography. Neurologia 2010;25(5):287-94. PMID 20643038
57: Goto Y, Matsushima T, Natori Y, Inamura T, Tobimatsu S. Delayed effects of the microvascular decompression on hemifacial spasm: a retrospective study of 131 consecutive operated cases. Neurol Res 2002;24(3):296-300. PMID 11958425
58: Gowers WR. A manual of diseases of the nervous system. London: J and A Churchill, 1888:228-37.
59: Hallett M, Albanese A, Dressler D, et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon 2013;67:94-114. PMID 23380701
60: Han IB, Chang JH, Chang JW, Huh R, Chung SS. Unusual causes and presentations of hemifacial spasm. Neurosurgery 2009;65(1):130-7. PMID 19574834
61: Heuser K, Kerty E, Eide PK, Cvancarova M, Dietrichs E. Microvascular decompression for hemifacial spasm: postoperative neurologic follow-up and evaluation of life quality. Eur J Neurol 2007;14(3):335-40. PMID 17355557
62: Holste K, Sahyouni R, Teton Z, Chan AY, Englot DJ, Rolston JD. Spasm freedom following microvascular decompression for hemifacial spasm: systematic review and meta-analysis. World Neurosurg 2020;139:e383-90. PMID 32305605
63: Huang CI, Chen IH, Lee LS. Microvascular decompression for hemifacial spasm: analyses of operative findings and results in 310 patients. Neurosurgery 1992;30:53-7. PMID 1738455
64: Hughes EC, Brackman DE, Weinstein RC. Seventh nerve spasm: effect of modification of cholinergic balance. Otolaryngol Head Neck Surg 1980;88:491-9. PMID 6821438
65: Huh R, Han IB, Moon JY, Chang JW, Chung SS. Microvascular decompression for hemifacial spasm: analyses of operative complications in 1582 consecutive patients. Surg Neurol 2008;69(2):153-7. PMID 18261641
66: Hyun SJ, Kong DS, Park K. Microvascular decompression for treating hemifacial spasm: lessons learned from a prospective study of 1174 operations. Neurosurg Rev 2010;33(3):325-34. PMID 20349099
67: Illingworth RD, Porter DG, Jakubowski J. Hemifacial spasm: a prospective long term follow up of 83 cases treated by microvascular decompression at two neurosurgical centres in the United Kingdom. J Neurol Neurosurg Psychiatry 1996;60:72-7. PMID 8558156
68: Incirli SU, Yilmaz R, Akbostanci MC. Hemifacial spasm in sleep - A polysomnographic study. J Clin Neurosci 2019;64:160-2. PMID 30902436
69: Ishikawa M, Nakanishi T, Takamiya Y, Namiki J. Delayed resolution of residual hemifacial spasm after microvascular decompression operations. Neurosurgery 2001;49:847-56. PMID 11564245
70: Ishikawa M, Ohira T, Namiki J, et al. Electrophysiological investigation of hemifacial spasm after microvascular decompression: F waves of the facial muscles, blink reflexes, and abnormal muscle responses. J Neurosurg 1997;86(4):654-61. PMID 9120630
71: Ishikawa M, Ohira T, Namiki J, Gotoh K, Takase M, Toya S. Electrophysiological investigation of hemifacial spasm: F-waves of the facial muscles. Acta Neurochir 1996;138:24-32. PMID 8686521
72: Ishikawa M, Takashima K, Kamochi H, Kusaka G, Shinoda S, Watanabe E. Treatment with botulinum toxin improves the hyperexcitability of the facial motoneuron in patients with hemifacial spasm. Neurol Res 2010;32(6):656-60. PMID 19660185
73: Ito M, Hasegawa M, Hoshida S, Miwa T, Furukawa M. Successful treatment of hemifacial spasm with selective facial nerve block using doxorubicin (adriamycin) under local anesthesia. Acta Otolaryngol 2004;124(2):217-20. PMID 15072429
74: Iwakuma T. Hemifacial spasm: comparison of three different operative procedures in 110 patients. J Neurosurg 1982;57:753-6. PMID 7143057
75: Janetta PJ. Cranial rhizopathies. In: Youmans JR, editor. Neurological surgery. 3rd ed. Philadelphia: W B Saunders, 1990:4169-82.
76: Jankovic, J. Etiology and differential diagnosis of blepharospasm and oromandibular dystonia. Adv Neurol 1988;49:103-16. PMID 3278535
77: Jeon CJ, Kong DS, Lee JA, Park K. The efficacy and safety of microvascular decompression for hemifacial spasm in elderly patients. J Korean Neurosurg Soc 2010;47(6):442-5. PMID 20617090
78: Jho HD, Janetta PJ. Hemifacial spasm in young people treated with microvascular decompression of the facial nerve. Neurosurgery 1987;20:767-70. PMID 3601024
79: Jog M, Chouinard S, Hobson D, et al. Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey. Can J Neurol Sci 2011;38(5):704-11. PMID 21856572
80: Kakizawa Y, Seguchi T, Kodama K, et al. Anatomical study of the trigeminal and facial cranial nerves with the aid of 3.0 tesla magnetic resonance imaging. J Neurosurg 2008;108(3):483-90. PMID 18312095
81: Kaye AH, Adams CB. Hemifacial spasm: a long term follow-up of patients treated by posterior fossa surgery and facial nerve wrapping. J Neurol Neurosurg Psychiatry 1981;44:1100-3. PMID 7334404
82: Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm 2008;115(4):585-91. PMID 17558461
83: Kim KJ, Kim JM, Kim SH, Bae YJ. Coexistence of ocular neuromyotonia and hemifacial spasm. Neurology 2016;86(4):402. PMID 26810424
84: Kiziltan ME, Uzun N, Savrun FK. Motor unit potential analysis in the cases with hemifacial spasm and postparalytic facial hyperactivity. Electromyogr Clin Neurophysiol 2005;45(1):23-8. PMID 15773260
85: Kojima A, Ohira T, Takase M, Kawase T. Long-latency response to transcranial magnetic stimulation in patients with hemifacial spasm. Electroencephalogr Clin Neurophysiol 1998;109:285-9. PMID 9751289
86: Kondo A, Ishikawa JI, Konishi T. The pathogenesis of hemifacial spasm: characteristic changes of vasculature in vertebrobasilar artery system. In: Samii M, Janetta PJ, editors. The cranial nerves. Berlin: Springer-Verlag, 1981:494-501.
87: Kong DS, Park K, Shin BG, Lee JA, Eum DO. Prognostic value of the lateral spread response for intraoperative electromyography monitoring of the facial musculature during microvascular decompression for hemifacial spasm. J Neurosurg 2007;106(3):384-7. PMID 17367059
88: Kuroda T, Saito Y, Fujita K, et al. Efficacy of levetiracetam in primary hemifacial spasm. J Clin Neurosci 2016;34:213-5. PMID 27460515
89: Kuroki A, Moller AR. Facial nerve demyelination and vascular compression are both needed to induce facial hyperactivity: a study in rats. Acta Neurochirugica 1994;126:149-57. PMID 8042548
90: Lee JA, Kong DS, Lee S, Park SK, Park K. Clinical outcome after microvascular decompression according to the progression rates of hemifacial spasm. World Neurosurg 2020;134:e985-90. PMID 31734426
91: Lee MS, Kim MS, Hong IS, Whang K, Han YP. Clinical usefulness of magnetic resonance cisternography in patients having hemifacial spasm. Yonsei Med J 2001;42:390-4. PMID 11519080
92: Lee SH, Rhee BA, Choi SK, Koh JS, Lim YJ. Cerebellopontine angle tumors causing hemifacial spasm: types, incidence, and mechanism in nine reported cases and literature review. Acta Neurochir (Wien) 2010;152(11):1901-8. PMID 20845049
93: Li Y, Peng C. Treatment of 86 cases of facial spasm by acupuncture and pressure on otopoints. J Tradit Chin Med 2000;20:33-5. PMID 10921167
94: Li YJ, Huang Y, Ding Q, Gu ZH, Pan XL. Evaluation of concentrations of botulinum toxin A for the treatment of hemifacial spasm: a randomized double-blind crossover trial. Genet Mol Res 2015;14(1):1136-44. PMID 25730053
95: Liu MX, Zhong J, Xia L, Dou NN, Li ST. A correlative analysis between inflammatory cytokines and trigeminal neuralgia or hemifacial spasm. Neurol Res 2019;41(4):335-40. PMID 30612530
96: Loeser JD, Chen J. Hemifacial spasm: treatment by microsurgical facial nerve decompression. Neurosurgery 1983;13:141-6. PMID 6888693
97: Lu AY, Yeung JT, Gerrard JL, Michaelides EM, Sekula RF Jr, Bulsara KR. Hemifacial spasm and neurovascular compression. ScientificWorldJournal 2014;2014:349319. PMID 25405219
98: Maurice-Williams RS. Tic convulsif: the association of trigeminal neuralgia and hemifacial spasm. Postgrad Med J 1973;49:742-5. PMID 4786441
99: Mehanna R, Jankovic J. Movement disorders in multiple sclerosis and other demyelinating diseases. J Neurol Sci 2013;328(1-2):1-8. PMID 23522528
100: Micheli F, Scorticati MC, Gatto E, Cerosimo G, Adi H. Familial hemifacial spasm. Mov Disord 1994;9:330-2. PMID 8041374
101: Mitsuoka H, Arai H, Tsunoda A, Okuda O, Sato K, Makita J. Microanatomy of the cerebellopontine angle and internal auditory canal: study with new magnetic resonance imaging technique using three-dimensional fast spin echo. Neurosurgery 1999;44:561-6. PMID 10069593
102: Miwa H, Mizuno Y, Kondo T. Familial hemifacial spasm: report of cases and review of literature. J Neurol Sci 2002;193(2):97-102. PMID 11790389
103: Moller AR. Interaction between the blink reflex and the abnormal muscle response in patients with hemifacial spasm: results of intraoperative recordings. J Neurol Sci 1991;101:114-23. PMID 2027024
104: Moller AR, Jannetta PJ. Physiological abnormalities in hemifacial spasm studied during microvascular decompression operations. Exp Neurol 1986;93:584-600. PMID 3743704
105: Moller MB, Moller AR. Loss of auditory function in microvascular decompression for hemifacial spasm. J Neurosurg 1985;63:17-20. PMID 4009269
106: Nakagawa I, Takayama K, Kurokawa S, et al. Hemifacial spasm due to contralateral aneurysmal compression of the facial nerve successfully treated with endovascular coil embolization: case report. Neurosurg 2011;69(3):E771-2. PMID 21832966
107: Nielsen VK. Pathophysiology of hemifacial spasm: I. Ephaptic transmission and ectopic excitation. Neurology 1984a;34:418-26. PMID 6322048
108: Nielsen VK. Pathophysiology of hemifacial spasm: II. Lateral spread of the supraorbital nerve reflex. Neurology 1984b;34:427-31. PMID 6322049
109: Ogale SB, Chopra S, Thakur S. Transtympanic facial nerve needling: a curative surgical option for hemifacial spasms. Acta Otolaryngol 1995;115:405-7. PMID 7653262
110: Oge AE, Yayla V, Demir GA, Eraksoy M. Excitability of facial nucleus and related brain-stem reflexes in hemifacial spasm, post-facial palsy synkinesis and facial myokymia. Clin Neurophysiol 2005;116:1542-54. PMID 15953558
111: Ogiwara M, Shimizu T. Surface rendered three-dimensional MR imaging for the evaluation of trigeminal neuralgia and hemifacial spasm. J Clin Neurosci 2004;11:840-4. PMID 15519859
112: Oh CH, Shim YS, Park H, Kim EY. A case of hemifacial spasm caused by an artery passing through the facial nerve. J Korean Neurosurg Soc 2015;57(3):221-4. PMID 25810866
113: Oizumi T, Ohira T, Kawase T. Angiographic manifestations and operative findings with 70 cases of hemifacial spasm: relation of common trunk anomalies. Keio J Med 2003;52(3):189-97. PMID 14529152
114: Palaram H, Carrera E, Vargas MI, Kleinschmidt A, Fleury V. Familial hemifacial spasm of young-onset: Report of two cases. J Neurol Sci 2017;373:83-5. PMID 28131234
115: Peeraully T, Hameed S, Cheong PT, et al. Complementary therapies in hemifacial spasm and comparison with other movement disorders. Int J Clin Pract 2013;67(8):801-6. PMID 23869681
116: Poff CB, Lipschitz N, Kohlberg GD, Breen JT, Samy RN. Hemifacial spasm as a rare clinical presentation of idiopathic intracranial hypertension: case report and literature review. Ann Otol Rhinol Laryngol 2020;129(8):829-32. PMID 32390451
117: Rakover Y, Dharan M, Rosen G. Hemifacial spasm associated with external carotid artery compression of the facial nerve. J Laryngol Otol 1996;110:1081-3. PMID 8944889
118: Ramirez-Castaneda J, Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel) 2013;5(2):249-66. PMID 23381141
119: Rudzinska M, Wojcik M, Hartel M, Szczudlik A. Tremor in hemifacial spasm patients. J Neural Transm 2011;118(2):241-7. PMID 21161713
120: Rushworth RG, Smith SF. Trigeminal neuralgia and hemifacial spasm. Med J Aus 1982;1:424-6. PMID 7099070
121: Samii M, Gunther T, Iaconetta G, Muehling M, Vorkapic P, Samii A. Microvascular decompression to treat hemifacial spasm: long-term results for a consecutive series of 143 patients. Neurosurgery 2002;50(4):712-8. PMID 11904020
122: Sanders DB. Ephaptic transmission in hemifacial spasm: a single-fiber EMG study. Muscle Nerve 1989;12:690-4. PMID 2550821
123: Sandyk R, Gillman MA. Baclofen in hemifacial spasm. Int J Neurosci 1987;33:261-4. PMID 3596953
124: Sato K, Ezura M, Takahashi A, Yoshimoto T. Fusiform aneurysm of the vertebral artery presenting hemifacial spasm treated by intravascular embolization. Case report. Surg Neurol 2001;56:52-5. PMID 11546578
125: Schultze F. Linksseitiger facialiskrampf in folge eines aneurysma der arteria vertebralis sinistra. Archiv f Pathol Anat 1875;65:385-91.
126: Sekula RF Jr, Frederickson AM, Branstetter BF 4th, et al. Thin-slice T2 MRI imaging predicts vascular pathology in hemifacial spasm: a case-control study. Mov Disord 2014;29(10):1299-303. PMID 25044001
127: Shimizu M, Suzuki Y, Kiyosawa M, et al. Glucose hypermetabolism in the thalamus of patients with hemifacial spasm. Mov Disord 2012;27(4):519-25. PMID 22344604
128: Shimzu S, Tanaka R, Sato S, Fujii K. Hemifacial spasm following a blow to the mandible causing blunt injury to the peripheral facial nerve. Neurol Med Chir (Tokyo) 2005;45:192-5. PMID 15849456
129: Shin JC, Chung UH, Kim YC, Park CI. Prospective study of microvascular decompression in hemifacial spasm. Neurosurgery 1997;40:730-4. PMID 9092846
130: Simpson DM, Blitzer A, Brashear A, et al. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;70(19):1699-706. PMID 18458230
131: Sindou M, Fobe JL, Ciriano D, Fischer C. Hearing prognosis and intraoperative guidance of brainstem auditory evoked potential in microvascular decompression. Laryngoscope 1992;102:678-82. PMID 1602916
132: Sprik C, Wirtschafter JD. Hemifacial spasm due to intracranial tumor. An international survey of botulinum toxin investigators. Ophthalmology 1988;95:1042-5. PMID 3266003
133: Stamey W, Jankovic J. The other Babinski sign in hemifacial spasm. Neurology 2007;69(4):402-4. PMID 17646635
134: Streitova H, Bares M. Long-term therapy of benign essential blepharospasm and facial hemispasm with botulinum toxin A: retrospective assessment of the clinical and quality of life impact in patients treated for more than 15 years. Acta Neurol Belg 2014;114(4):285-91. PMID 24604684
135: Tambasco N, Filidei M, Nigro P, Parnetti L, Simoni S. Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies. Toxins (Basel) 2021;13(12):881. PMID 34941718
136: Tan EK, Chan LL. Young onset hemifacial spasm. Acta Neurol Scand 2006;114:59-62. PMID 16774629
137: Tan EK, Chan LL, Koh KK. Coexistent blepharospasm and hemifacial spasm: overlapping pathophysiologic mechanism. J Neurol Neurosurg Psychiatry 2004a;75(3):494-6. PMID 14966174
138: Tan EK, Fook-Chong S, Lum SY, Lim E. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30). J Neurol Sci 2004b;219(1-2):151-5. PMID 15050451
139: Tarnaris A, Renowden S, Coakham HB. A comparison of magnetic resonance angiography and constructive interference in steady state-three-dimensional Fourier transformation magnetic resonance imaging in patients with hemifacial spasm. Br J Neurosurg 2007;21(4):375-81. PMID 17676458
140: Tash R, DeMerritt J, Sze G, Leslie D. Hemifacial spasm: MR imaging features. Am J Neuroradiol 1991;12:839-42. PMID 1950907
141: Thomas KL, Hughes MA, Frederickson AM, Branstetter BF 4th, Vilensky JA, Sekula RF. Hemifacial spasm caused by an aberrant jugular branch of the ascending pharyngeal artery. Br J Neurosurg 2014:1-3. PMID 25232808
142: Tien RD, Wilkins RH. MRA delineation of the vertebral-basilar system in patients with hemifacial spasm and trigeminal neuralgia. Am J Neuroradiol 1993;14:34-6. PMID 8427109
143: Trosch RM, Adler CH, Pappert EJ. Botulinum toxin type B (Myobloc(R)) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety study. Mov Disord 2007;22(9):1258-64. PMID 17588242
144: Tu Y, Yu T, Wei Y, Sun K, Zhao W, Yu B. Structural brain alterations in hemifacial spasm: A voxel-based morphometry and diffusion tensor imaging study. Clin Neurophysiol 2016;127(2):1470-4. PMID 26424116
145: Tugend M, Ulane CM, Patel K, Sekula RF. Decompression surgery in elderly patients with hemifacial spasm refractory to botulinum toxin. Mov Disord Clin Pract 2024;11(8):966-72. PMID 38779725
146: von Eckardstein K, Harper C, Castner M, Link M. The significance of intraoperative electromyographic "lateral spread" in predicting outcome of microvascular decompression for hemifacial spasm. J Neurol Surg B Skull Base 2014;75(3):198-203. PMID 25072013
147: Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve 1998;21(12):1740-7. PMID 9843077
148: Wang L, Hu X, Dong H, et al. Clinical features and treatment status of hemifacial spasm in China. Chin Med J (Engl) 2014;127(5):845-9. PMID 24571874
149: Wang X, Thirumala PD, Shah A, et al. Effect of previous botulinum neurotoxin treatment on microvascular decompression for hemifacial spasm. Neurosurg Focus 2013;34(3):E3. PMID 23452316
150: Wilkins RH. Hemifacial spasm: a review. Surg Neurol 1991;36:251-77. PMID 1948626
151: Wilkins RH. Hemifacial spasm and other facial nerve dysfunction syndromes. In: Barrow DL, editor. Surgery of the cranial nerves of the posterior fossa. American Association of Neurological Surgeons, 1993:221-33.
152: Wilkinson MF, Chowdhury T, Mutch WA, Kaufmann AM. Is hemifacial spasm a phenomenon of the central nervous system? - The role of desflurane on the lateral spread response. Clin Neurophysiol 2015;126(7):1354-9. PMID 25454282
153: Wilson CB, Yorke C, Prioleau G. Microsurgical vascular decompression for trigeminal neuralgia and hemifacial spasm. West J Med 1980;132:481-4. PMID 7405198
154: Wirtschafter JD, McLoon LK. Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm. Ophthalmology 1998;105:342-6. PMID 9479297
155: Wu Y, Davidson AL, Pan T, Jankovic J. Asian over-representation among patients with hemifacial spasm compared to patients with cranial-cervical dystonia. J Neural Sci 2010;298(1-2):61-3. PMID 20864122
156: Xu F, Gu P, Yuan H, et al. Analysis of risk factors related to the progression rate of hemifacial spasm. Front Neurol 2024;15:1357280. PMID 38606273
157: Xu XL, Zhen XK, Yuan Y, et al. Long-term outcome of repeat microvascular decompression for hemifacial spasm. World Neurosurg 2018;110:e989-97. PMID 29203317
158: Yaltho TC, Jankovic J. The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord 2011;26(9):1582-92. PMID 21469208
159: Ying T, Thirumala P, Shah A, et al. Incidence of high-frequency hearing loss after microvascular decompression for hemifacial spasm. J Neurosurg 2013;118(4):719-24. PMID 23394342
160: Zhao H, Li GF, Zhang X, et al. Long-term efficacy of initial microvascular decompression versus subsequent microvascular decompression for idiopathic hemifacial spasm. World Neurosurg 2018;109:e778-82. PMID 29074421

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Toby C Yaltho MD

Dr. Yaltho of Houston Methodist Sugar Land Neurology Associates received honorariums from Abbvie and Supernus for speaking engagements.
See Profile

Editor

Robert Fekete MD

Dr. Fekete of New York Medical College received consultation fees from Acadia Pharmaceutical, Acorda, Adamas/Supernus Pharmaceuticals, Amneal/Impax, Kyowa Kirin, Lundbeck Inc., Neurocrine Inc., and Teva Pharmaceutical, Inc.
See Profile

Former Authors

Kathleen M Shannon MD

Patient Profile

Age range of presentation: 0 month to 65+ years
Sex preponderance: female>male, >1:1
Heredity: heredity may be a factor
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-10: Hemifacial spasm: G51.3

Hemifacial spasm, right-sided presentation: G51.31

Hemifacial spasm, left-sided presentation: G51.32
ICD-11: Hemifacial spasm: 8B88.2
OMIM: Hemifacial spasm: 141405

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Hemifacial spasm

Associated Disorders

Hearing loss due to stapedius muscle spasm
Neurovascular compression
Tinnitus (Subjective tinnitus)
Tremors
Trigeminal neuralgia (Trigeminal neuralgia and other cranial neuralgias)

Differential Diagnosis

Blepharospasm
Facial myokymia (Neuromyotonia and myokymia)
Focal clonic seizures
Myoclonus
Oromandibular dystonia
- Tardive dyskinesia
- Tic (Tourette syndrome)

Also Relevant

Ambiguous paroxysmal events
Bell palsy
Blepharospasm
Botulinum toxin treatment of neurologic disorders
Epidemiology of movement disorders
- Functional (psychogenic) movement disorders
- Neuro-ophthalmology of movement disorders
- Paroxysmal dyskinesias

Clinical Categories

Movement Disorders

Patient Handouts

Hemifacial spasm

Web References

Clinical Trials

NIH: Hemifacial Spasm

Hemifacial spasm …

Hemifacial spasm

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Wilson disease

Neuroacanthocytosis

Restless legs syndrome

Dementia in Parkinson disease

ALS-like disorders of the Western Pacific

Sleep-related leg cramps

Sleep and cerebral degenerative disorders

Progressive supranuclear palsy: cognitive and behavioral changes

Hemifacial spasm

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Wilson disease

Neuroacanthocytosis

Restless legs syndrome

Dementia in Parkinson disease

ALS-like disorders of the Western Pacific

Sleep-related leg cramps

Sleep and cerebral degenerative disorders

Progressive supranuclear palsy: cognitive and behavioral changes

This is an article preview.
Start a Free Account
to access the full version.